Abstract
Previously, we proposed a novel mouse model for colitis‐related colon carcinogenesis using azoxymethane (AOM) and dextran sodium sulfate (DSS) (Cancer Sci 2003; 94: 965–73). In the current study, sequential analysis of pathological alterations during carcinogenesis in our model was conducted to establish the influence of inflammation caused by DSS on colon carcinogenesis in this model. Male ICR mice were given a single intraperitoneal injection of AOM (10 mg/kg body weight) and given 2% (w/v) DSS in the drinking water for 7 days, starting 1 week after the AOM injection. They were sequentially sacrificed at weeks 2, 3, 4, 5, 6, 9, 12, and 14 for histopathological and immunohistochemical examinations. Colonic adenomas were found in 2 (40% incidence and 0.40±0.49 multiplicity) of 5 mice at week 3 and colon carcinomas developed in 2 (40% incidence and 2.00±3.52 multiplicity) of 5 mice at week 4. Their incidence gradually increased with time and reached 100% (6.20±2.48 multiplicity) at week 6. At week 14, the multiplicity of adenocarcinoma was 9.75±2.49 (100% incidence). In addition, colonic dysplasia was noted at all time‐points. The scores of colonic inflammation and nitrotyrosine immunohistochemistry were extremely high at early time‐points and were well correlated. Our results suggest that combined treatment of mice with AOM and DSS generates neoplasms in the colonic mucosa via dysplastic lesions induced by nitrosative stress.
Abbreviations:
- AOM
azoxymethane
- DSS
dextran sodium sulfate
- CRC
colorectal cancer
- IBD
inflammatory bowel disease
- UC
ulcerative colitis
- CD
Crohn's disease
- iNOS
inducible nitric oxide synthase
- i.p.
intraperitoneal
- NO
nitric oxide
- COX
cyclooxygenase
References
- 1. Potter JD. Risk factors for colon neoplasia‐epidemiology and biology. Eur J Cancer 1995; 31:1033–8. [DOI] [PubMed] [Google Scholar]
- 2. Grossman A, Fireman Z, Lilos P, Novis B, Rozen P, Gilat T. Epidemiology of ulcerative colitis in the Jewish population of central Israel 1970–1980. Hepatogastroentemlogy 1989; 36: 193–7. [PubMed] [Google Scholar]
- 3. Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation of inflammatory bowel disease within the United States. Gastroenterology 1991; 100: 143–9. [DOI] [PubMed] [Google Scholar]
- 4. Reif S, Klein I, Lubin F, Farbstein M, Hallak A, Gilat T. Pre‐illness dietary factors in inflammatory bowel disease. Gut 1997; 40: 754–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Rampton DS, Phil D. New treatments for inflammatory bowel disease. World J Gastroenterol 1998; 4: 369–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Fujimoto K. IBD and feeding behavior. Pathol Clin Med 2002; 20: 1226–30 (in Japanese). [Google Scholar]
- 7. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta‐analysis. Gut 2001; 48: 526–35. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. van Hogezand RA, Eichhorn RF, Choudry A, Veenendaal RA, Lamers CB. Malignancies in inflammatory bowel disease: fact or fiction Scand J Gastroenterol Suppl 2002; 236: 48–53. [DOI] [PubMed] [Google Scholar]
- 9. Weedon DD, Shorter RG, Ilstrup DM, Huizenga KA, Taylor WE Crohn's disease and cancer. N Engl J Med 1973; 289: 1099–103. [DOI] [PubMed] [Google Scholar]
- 10. Gillen CD, Walmsley RS, Prior P, Adndrews HA, Allan RN. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 1994; 35: 1590–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Marcus R, Watt J. Colonic ulceration in young rats fed degraded carrageenan. Lancet 1971; ii: 765–6. [DOI] [PubMed] [Google Scholar]
- 12. Seril DN, Liao J, Yang GY, Yang CS. Oxidative stress and ulcerative colitis‐associated carcinogenesis: studies in humans and animal models. Carcinogenesis 2003; 24: 353–62. [DOI] [PubMed] [Google Scholar]
- 13. Hirono I, Kuhara K, Hosaka S, Tomizawa S, Golberg L. Induction of intestinal tumors in rats by dextran sulfate sodium. J Natl Cancer Inst 1981; 66: 579–83. [PubMed] [Google Scholar]
- 14. Tamaru T, Kobayashi H, Kishimoto S, Kajiyama G, Shimamoto F, Brown WR. Histochemical study of colonic cancer in experimental colitis of rats. Dig Dis Sci 1993; 38: 529–37. [DOI] [PubMed] [Google Scholar]
- 15. Cooper HS, Murthy S, Kido K, Yoshitake H, Flanigan A. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis‐associated neoplasia in the human: a study of histopathology, β‐catenin and p53 expression and the role of inflammation. Carcinogenesis 2000; 21: 757–68. [DOI] [PubMed] [Google Scholar]
- 16. Yamada M, Ohkusa T, Okayasu I. Occurrence of dysplasia and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulphate sodium. Gut 1992; 33: 1521–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Tanaka T, Kohno H, Yoshitani S, Takashima S, Okumura A, Murakami A, Hosokawa M. Ligands for peroxisome proliferator‐activated receptors α and γ inhibit chemically induced colitis and formation of aberrant crypt foci in rats. Cancer Res 2001; 61: 2424–8. [PubMed] [Google Scholar]
- 18. Tanaka T, Kohno H, Suzuki R, Yamada Y, Sugie S, Mori H. A novel inflammation‐related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 2003; 94: 965–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Singer II, Kawka DW, Scott S, Weidner JR, Mumford RA, Riehl TE, Stenson WF. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996; 111: 871–85. [DOI] [PubMed] [Google Scholar]
- 20. Kimura H, Hokari R, Miura S, Shigematsu T, Hirokawa M, Akiba Y, Kurose I, Higuchi H, Fujimori H, Tsuzuki Y, Serizawa H, Ishii H. Increased expression of an inducible isoform of nitric oxide synthase and the formation of peroxynitrite in colonic mucosa of patients with active ulcerative colitis. Gut 1998; 42: 180–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Zingarelli B, Szabo C, Salzman AL. Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase. Gut 1999; 45: 199–209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Beckman JS. Oxidative damage and tyrosine nitration from peroxynitrite. Chem Res Toxicol 1996; 9: 836–44. [DOI] [PubMed] [Google Scholar]
- 23. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993; 69: 238–49. [PubMed] [Google Scholar]
- 24. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, Ahren C, Correa P, Hamilton SR, Morson BC. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983; 14: 931–68. [DOI] [PubMed] [Google Scholar]
- 25. Pascal RR. Dysplasia and early carcinoma in inflammatory bowel disease and colorectal adenomas. Hum Pathol 1994; 25: 1160–71. [DOI] [PubMed] [Google Scholar]
- 26. Ward JM. Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. Lab Invest 1974; 30: 505–13. [PubMed] [Google Scholar]
- 27. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694–702. [DOI] [PubMed] [Google Scholar]
- 28. Ni J, Chen SF, Hollander D. Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes. Gut 1996; 39: 234–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Kitajima S, Takuma S, Morimoto M. Tissue distribution of dextran sulfate sodium (DSS) in the acute phase of murine DSS‐induced colitis. J Vet Med Sci 1999; 61: 67–70. [DOI] [PubMed] [Google Scholar]
- 30. Kankuri E, Hamalainen M, Hukkanen M, Salmenpera P, Kivilaakso E, Vapaatalo H, Moilanen E. Suppression of pro‐inflammatory cytokine release by selective inhibition of inducible nitric oxide synthase in mucosal explants from patients with ulcerative colitis. Scand J Gastroenterol 2003; 38: 186–92. [DOI] [PubMed] [Google Scholar]
- 31. Halliwell B. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo FEBS Lett 1997; 411: 157–60. [DOI] [PubMed] [Google Scholar]
- 32. Ambs S, Merriam WG, Bennett WP, Felley‐Bosco E, Ogunfusika MO, Oser SM, Klein S, Shields PG, Billiar TR, Harris CC. Frequent nitric oxide synthase‐2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res 1998; 58: 334–41. [PubMed] [Google Scholar]
- 33. Takahashi M, Mutoh M, Kawamori T, Sugimura T, Wakabayashi K. Altered expression of β‐catenin, inducible nitric oxide synthase and cyclooxygenase‐2 in azoxymethane‐induced rat colon carcinogenesis. Carcinogenesis 2000; 21: 1319–27. [PubMed] [Google Scholar]
- 34. Yamada Y, Yoshimi N, Hirose Y, Matsunaga K, Katayama M, Sakata K, Shimizu M, Kuno T, Mori H. Sequential analysis of morphological and biological properties of β‐catenin‐accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res 2001; 61: 1874–8. [PubMed] [Google Scholar]
- 35. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. Up‐regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroentewlogy 1994; 107: 1183–8. [DOI] [PubMed] [Google Scholar]
- 36. Klaunig JE, Kamendulis LM. The role of oxidative stress in carcinogenesis. Annu Rev Pharmacol Toxicol 2004; 44: 239–67. [DOI] [PubMed] [Google Scholar]
- 37. Hussain SP, Hofseth LJ, Harris CC. Radical causes of cancer. Nat Rev Cancer 2003; 3: 276–85. [DOI] [PubMed] [Google Scholar]
- 38. 1 Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004; 287: G7–17. [DOI] [PubMed] [Google Scholar]
- 39. Tanaka T, Kawabata K, Kakumoto M, Kara A, Murakami A, Kuki W, Takahashi Y, Yonei H, Maeda M, Ota T, Odashima S, Yamane T, Koshimizu K, Ohigashi H. Citrus auraptene exerts dose‐dependent chemopreventive activity in rat large bowel tumorigenesis: the inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug‐metabolizing enzymes. Cancer Res 1998; 58: 2550–6. [PubMed] [Google Scholar]
- 40. Lih‐Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, Weissman GS, Katz S, Floyd RA, McKinley MJ, Fisher SE, Mullin GE. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996; 41: 2078–86. [DOI] [PubMed] [Google Scholar]
- 41. Bartsch H, Nair J. Potential role of lipid peroxidation derived DNA damage in human colon carcinogenesis: studies on exocyclic base adducts as stable oxidative stress markers. Cancer Detect Prev 2002; 26: 308–12. [DOI] [PubMed] [Google Scholar]
- 42. D'Inca R, Cardin R, Benazzato L, Angriman I, Martines D, Sturniolo GC. Oxidative DNA damage in the mucosa of ulcerative colitis increases with disease duration and dysplasia. Inflamm Bowel Dis 2004; 10: 23–7. [DOI] [PubMed] [Google Scholar]
- 43. Tardieu D, Jaeg JP, Cadet J, Embvani E, Corpet DE, Petit C. Dextran sulfate enhances the level of an oxidative DNA damage biomarker, 8‐oxo‐7,8‐dihydro‐2′‐deoxyguanosine, in rat colonic mucosa. Cancer Lett 1998; 134: 1–5. [DOI] [PubMed] [Google Scholar]
- 44. Araki Y, Andoh A, Fujiyama Y. The free radical scavenger edaravone suppresses experimental dextran sulfate sodium‐induced colitis in rats. Int J Mol Med 2003; 12: 125–9. [PubMed] [Google Scholar]